FDA grants RMAT designation to Aspen's Parkinson's cell therapy, speeding development and review process.
Aspen Neuroscience received the FDA's Regenerative Medicine Advanced Therapy (RMAT) designation for sasineprocel, its investigational autologous cell therapy for Parkinson's disease. This designation allows for expedited development and review, inclu...
